Yarrow Bioscience, Inc. (YARW) Form 10-Q Quarterly Reports
Yarrow Bioscience, Inc. (YARW) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: YARW
CIK: 1566044
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Baker Tilly US, LLP
Auditor SinceSince 12/31/2022 12:00:00 AM
Lead Engagement PartnerKristen Godsoe
Audit LocationTewksbury, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G | 2026-10-07 | — | SCHEDULE 13G Filing | 0001104659-26-114282 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-09-17 | — | SCHEDULE 13G Filing | 0002005369-26-000053 | View SEC Doc Filr Page |
| 8-K | 2026-09-14 | 2026-09-10 | FORM 8-K | 0001104659-26-107485 | View SEC Doc Filr Page |
| 424B5 | 2026-09-11 | — | 424B5 | 0001104659-26-107112 | View SEC Doc Filr Page |
| 424B5 | 2026-09-11 | — | 424B5 | 0001104659-26-107102 | View SEC Doc Filr Page |
| 8-K | 2026-09-10 | 2026-09-10 | FORM 8-K | 0001104659-26-106699 | View SEC Doc Filr Page |
| EFFECT | 2026-08-19 | — | EFFECT Filing | 9999999995-26-002706 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0001104659-26-097426 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0000905148-26-003761 | View SEC Doc Filr Page |
| POS AM | 2026-08-14 | — | POS AM | 0001104659-26-096109 | View SEC Doc Filr Page |
| 8-K/A | 2026-08-13 | 2026-07-24 | FORM 8-K/A | 0001104659-26-095925 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | 10-Q | 0001566044-26-000010 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-13 | — | SCHEDULE 13G/A Filing | 0002140685-26-000004 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-07 | — | SCHEDULE 13G/A Filing | 0000935836-26-000377 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-07 | — | SCHEDULE 13G Filing | 0001274173-26-000185 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-08-05 | — | SCHEDULE 13D Filing | 0000947871-26-000747 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-04 | — | SCHEDULE 13G Filing | 0000935836-26-000371 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-03 | — | SCHEDULE 13G Filing | 0001193125-26-330498 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-30 | — | SCHEDULE 13G Filing | 0001104659-26-088671 | View SEC Doc Filr Page |
| 4 | 2026-07-30 | 2026-07-29 | OWNERSHIP DOCUMENT | 0001104659-26-088665 | View SEC Doc Filr Page |
| 8-K | 2026-07-30 | 2026-07-29 | FORM 8-K | 0001104659-26-088662 | View SEC Doc Filr Page |
| 3 | 2026-07-30 | 2026-07-27 | OWNERSHIP DOCUMENT | 0001104659-26-088658 | View SEC Doc Filr Page |
| 4 | 2026-07-29 | 2026-07-27 | OWNERSHIP DOCUMENT | 0001104659-26-088371 | View SEC Doc Filr Page |
| 4 | 2026-07-29 | 2026-07-27 | OWNERSHIP DOCUMENT | 0001104659-26-088370 | View SEC Doc Filr Page |
| 3 | 2026-07-29 | 2026-07-27 | OWNERSHIP DOCUMENT | 0001104659-26-088369 | View SEC Doc Filr Page |